Terry Wood, head of liquid store centre of emphasis at Pfizer Global R+D, left Compound Management and Integrity 2007 vowing to return in 2008 - a promise about to be kept
Wood returns by popular demand; last year delegates noted his style and breadth of his expertise in his role as chairperson and round table leader as he focussed on the topical issue of integrating CM with other functions.
2008 sees Wood present on 'The management of compound management: how to get buy in for CM' covering managing change in the collaborative role of CM in the drug discovery organisation through flexibility; responding to new requirements and trends in target based screening as well as the much coveted secret to success of managing a CM team and steps on how to demonstrate the value of CM to key partners.
Other new elements introduced to this year's event include:.
Co-locating Compound Management with Lead Finding Screening to ensure broader networking opportunities.
30 new sessions and speakers, including Ricardo Macarron, vice president of compound management, GlaxoSmithKline and president of the SBS.
A new focus day on how to improve the critical interface and workflow between compound management and screening.
Many leading industry figures have published comments on the annual Compound Management events: "Great as usual - best place to have face-to-face conversations with leaders in the CM community" was just one opinion voiced by Ioana Popa-Burke, head of Sharp at GlaxoSmithKline.
Eva Maria Gutknecht, head of compound logistics at Hoffman La Roche, described the event as the "Most valuable conference for CM...
excellent presentations...
good networking...
a source of new ideas for implementation."
